PH12021551428A1 - Recombinant avian herpes viruses containing multiple foreign genes - Google Patents

Recombinant avian herpes viruses containing multiple foreign genes

Info

Publication number
PH12021551428A1
PH12021551428A1 PH12021551428A PH12021551428A PH12021551428A1 PH 12021551428 A1 PH12021551428 A1 PH 12021551428A1 PH 12021551428 A PH12021551428 A PH 12021551428A PH 12021551428 A PH12021551428 A PH 12021551428A PH 12021551428 A1 PH12021551428 A1 PH 12021551428A1
Authority
PH
Philippines
Prior art keywords
containing multiple
herpes viruses
viruses containing
foreign genes
recombinant avian
Prior art date
Application number
PH12021551428A
Other languages
English (en)
Inventor
Ayumi Fujisawa
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of PH12021551428A1 publication Critical patent/PH12021551428A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH12021551428A 2018-12-21 2021-06-17 Recombinant avian herpes viruses containing multiple foreign genes PH12021551428A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306798 2018-12-21
PCT/EP2019/086670 WO2020127964A1 (en) 2018-12-21 2019-12-20 Recombinant avian herpes viruses containing multiple foreign genes

Publications (1)

Publication Number Publication Date
PH12021551428A1 true PH12021551428A1 (en) 2021-12-06

Family

ID=65628501

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12021551428A PH12021551428A1 (en) 2018-12-21 2021-06-17 Recombinant avian herpes viruses containing multiple foreign genes

Country Status (13)

Country Link
US (1) US20220040287A1 (zh)
EP (1) EP3897709A1 (zh)
JP (1) JP2022515172A (zh)
KR (1) KR20210108971A (zh)
CN (1) CN113226363A (zh)
BR (1) BR112021012032A2 (zh)
CA (1) CA3123174A1 (zh)
CO (1) CO2021007958A2 (zh)
MX (1) MX2021007408A (zh)
PE (1) PE20220232A1 (zh)
PH (1) PH12021551428A1 (zh)
WO (1) WO2020127964A1 (zh)
ZA (1) ZA202103810B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11596687B2 (en) 2016-06-17 2023-03-07 Intervet Inc. Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
US11464849B2 (en) 2019-09-11 2022-10-11 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
JP2023545524A (ja) 2020-10-15 2023-10-30 セヴァ サンテ アニマレ 組換えｈｖｔ及びその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1026246B1 (en) 1997-10-03 2006-11-29 Zeon Corporation Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
DE10129971A1 (de) 2001-06-21 2003-01-02 Ina Schaeffler Kg Kolben für Zylinder von hydraulischen Anlagen
US6866852B2 (en) * 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
JPWO2005093070A1 (ja) 2004-03-29 2008-02-14 日本ゼオン株式会社 組み換えヘルペスウイルス及びその利用
JP2008228658A (ja) 2007-03-20 2008-10-02 Nippon Zeon Co Ltd 新規なプロモーター、これを有する組み換え七面鳥ヘルペスウイルス、及びこれを利用した家禽用ワクチン
CN105567648B (zh) * 2009-04-15 2019-09-03 法国诗华大药厂 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗
CA2851658C (en) 2011-10-21 2022-03-15 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
LT3251691T (lt) * 2011-11-30 2020-02-10 Boehringer Ingelheim Animal Health USA Inc. Rekombinantiniai hvt vektoriai, ekspresuojantys paukščių patogenų antigenus, ir jų panaudojimas
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN103740759B (zh) * 2014-01-20 2016-04-06 中国农业科学院哈尔滨兽医研究所 表达h5n1亚型禽流感病毒ha基因的重组火鸡疱疹病毒
CN106399267A (zh) * 2016-10-28 2017-02-15 扬州大学 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法
CN106701693A (zh) * 2017-01-19 2017-05-24 北京邦卓生物科技有限公司 表达血清ⅰ型马立克氏病病毒gb基因的重组火鸡疱疹病毒的构建及其应用
CN107815469A (zh) * 2017-10-16 2018-03-20 北京市农林科学院 一种重组火鸡疱疹病毒及其制备方法
CN108543067A (zh) * 2017-12-25 2018-09-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 共表达h5亚型禽流感ha蛋白和传染性法氏囊vp2蛋白的重组火鸡疱疹病毒疫苗株

Also Published As

Publication number Publication date
CN113226363A (zh) 2021-08-06
KR20210108971A (ko) 2021-09-03
MX2021007408A (es) 2021-07-15
CA3123174A1 (en) 2020-06-25
BR112021012032A2 (pt) 2021-11-16
CO2021007958A2 (es) 2021-09-30
EP3897709A1 (en) 2021-10-27
ZA202103810B (en) 2023-07-26
PE20220232A1 (es) 2022-02-07
JP2022515172A (ja) 2022-02-17
US20220040287A1 (en) 2022-02-10
WO2020127964A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
PH12021551428A1 (en) Recombinant avian herpes viruses containing multiple foreign genes
PH12020550051A1 (en) Glp-1 compositions and uses thereof
MX2022003906A (es) Aislado de proteina de maiz y metodos de manufacturacion del mismo.
IL290633B1 (en) 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses
MA52645B1 (fr) Vaccins contre le virus respiratoire
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
PH12018502714A1 (en) Nicotine particles and compositions
PH12018500379A1 (en) Biopharmaceutical compositions
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
WO2017136450A3 (en) Compounds and methods of treating rna-mediated diseases
MX2020001885A (es) Formulaciones de daptomicina.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
WO2017011340A3 (en) Proteins and immunizing compositions containing klebsiella proteins and methods of use
IL290535A (en) Preparations, formulations, production and purification of interleukin
IL283430B (en) Formulations that include recombinant acid alpha-glucosidase
MX2020008125A (es) Composiciones que comprenden berberina.
WO2018226992A8 (en) Tau aggregation inhibitors
MY187334A (en) Xylanase
MX2018003162A (es) Variante en el numero de copias que genera resistencia a virus.
MX2022003754A (es) Composiciones para el cuidado bucal que comprenden acido beta de lupulo y fluoruro.
PH12020551618A1 (en) Erenumab compositions and uses thereof
GB2568440A (en) Modified factor H binding protein
MX2018000614A (es) Composiciones, organismos, sistemas y métodos para cítricos resistentes a patógenos.
IL283318A (en) Methods for preparing nitrogen oxides of propanediol, preparations including them and their medical uses
ZA202005050B (en) Polypeptide, compositions and uses thereof